Resonant Capital Advisors’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Resonant Capital Advisors's EXEL Position: Q2 2026 in Review
Resonant Capital Advisors increased its Exelixis (EXEL) stake by 0.6% in Q2 2026, buying an estimated $4.14K and bringing the position to 14,229 shares worth $774K. The position accounts for 0.04% of the portfolio, ranked #223.
Resonant Capital Advisors first reported a position in EXEL in Q4 2019 and has held it in 20 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Resonant Capital Advisors held 14,229 shares of Exelixis worth $774K as of Q2 2026.
- Resonant Capital Advisors bought 85 Exelixis shares in Q2 2026, an estimated $4.14K.
- Exelixis made up 0.04% of Resonant Capital Advisors's portfolio in Q2 2026, its #223 holding.
- Resonant Capital Advisors first reported a position in Exelixis in Q4 2019 and has held it in 20 quarters since.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.